Page last updated: 2024-10-30

metformin and Kawasaki Disease

metformin has been researched along with Kawasaki Disease in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Marek-Iannucci, S1
Ozdemir, AB1
Moreira, D1
Gomez, AC1
Lane, M1
Porritt, RA1
Lee, Y1
Shimada, K1
Abe, M1
Stotland, A1
Zemmour, D1
Parker, S1
Sanchez-Lopez, E1
Van Eyk, J1
Gottlieb, RA1
Fishbein, MC1
Karin, M1
Crother, TR1
Rivas, MN1
Arditi, M1

Other Studies

1 other study available for metformin and Kawasaki Disease

ArticleYear
Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis.
    JCI insight, 2021, 09-22, Volume: 6, Issue:18

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Autophagy; Autophagy-Related Proteins; Butanes; Cell Extracts;

2021